On Friday night, the Stephens County Sheriff's Office and Georgia State Patrol responded to Ingles/Belk parking lot after officers discovered a bomb inside a vehicle.During a routine traffic stop ...

Some of the key takeaways from the DeepSeek scare: It was a reminder of the outsized role tech stocks have right now in terms of driving market direction. The bulk of the bull run over the last ...

China’s reported breakthrough in artificial intelligence (AI) would prompt the US to seek a stronger alliance with Taiwan and Japan to secure its technological superiority, a Taiwanese researcher said ...

As the Wests Tigers attempt to bounce back from three miserable years, an injury scare for their big-name recruit has rocked the club. With positive energy emanating out of the Tigers’ 2025 pre ...

Authorities have not yet provided an official statement about the nature of the investigation or the item that triggered the scare. Residents and cast members praised the timely response of law ...

HMPV virus China: Britain is on high alert as a surge in human metapneumovirus cases prompts health warnings and calls for Britons to wear masks. Social media posts showed hospital wards overflowing ...

Love movies? Live for TV? USA TODAY's Watch Party newsletter has all the best recommendations, delivered right to your inbox. Sign up now and be one of the cool kids. There's a werewolf lurking ...

Before joining Raw Story, Brad Reed spent eight years writing about technology at BGR.com and Network World. Prior to that, he wrote freelance stories for political publications such as AlterNet ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...